Cargando…
Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection
Background. Liver fibrosis is accelerated in HIV and hepatitis C coinfection, mediated by profibrotic effects of angiotensin. The objective of this study was to determine if angiotensin converting enzyme inhibitors (ACE-Is) attenuate liver fibrosis in coinfection. Methods. A retrospective review of...
Autores principales: | Reese, Lindsey J., Tider, Diane S., Stivala, Alicia C., Fishbein, Dawn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501811/ https://www.ncbi.nlm.nih.gov/pubmed/23193466 http://dx.doi.org/10.1155/2012/978790 |
Ejemplares similares
-
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis
por: Miranda, Aline Silva, et al.
Publicado: (2017) -
Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B
por: Noguchi, Ryuichi, et al.
Publicado: (2017) -
Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)